cedazuridine,decitabine,venetoclax,azacitidine
abbvie,Roche
['mds', 'decitabine', 'decitabine,cedazuridine']
decitabine/cedazuridine in high risk mds and cmml . complete remission ~25% and 50% received bmt with &gt;60% survival after year. #eha2023 
@TheEBMT_Trainee co-chair. Hematology. Medicine. Science. Train. Think. Implement an integral actuality.